These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 19481700)

  • 1. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.
    Ishihara T; Kubota T; Choi T; Higaki M
    J Pharmacol Exp Ther; 2009 May; 329(2):412-7. PubMed ID: 19244548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.
    Ishihara T; Izumo N; Higaki M; Shimada E; Hagi T; Mine L; Ogawa Y; Mizushima Y
    J Control Release; 2005 Jun; 105(1-2):68-76. PubMed ID: 15955367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
    Ben-Shabat S; Kumar N; Domb AJ
    Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers.
    Beletsi A; Panagi Z; Avgoustakis K
    Int J Pharm; 2005 Jul; 298(1):233-41. PubMed ID: 15936907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.
    Liu H; Finn N; Yates MZ
    Langmuir; 2005 Jan; 21(1):379-85. PubMed ID: 15620328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents.
    Ishihara T; Takahashi M; Higaki M; Mizushima Y; Mizushima T
    Int J Pharm; 2010 Jan; 385(1-2):170-5. PubMed ID: 19837147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Jan; 68(1):105-11. PubMed ID: 17870446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.
    Hiemstra C; Zhong Z; Li L; Dijkstra PJ; Feijen J
    Biomacromolecules; 2006 Oct; 7(10):2790-5. PubMed ID: 17025354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.